Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shufeng Zhou

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 26, 2002
Strain differences in the liver microsomal metabolism of the experimental anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in miceShufeng Zhou, Philip Kestell, James W Paxton
Clinical and Experimental Pharmacology & Physiology|January 17, 2016
Multifaceted ability of naturally occurring polyphenols against metastatic cancerQingyu Zhou, Lunawati L Bennett, Shufeng Zhou
Drug Metabolism Reviews|April 10, 2004
Herbal modulation of P-glycoproteinShufeng Zhou, Lee Yong Lim, Balram Chowbay
The Journal of Pharmacy and Pharmacology|August 7, 2002
Non-specific binding of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in liver microsomes from various speciesShufeng Zhou, Philip Kestell, James W Paxton
Drug Metabolism Reviews|December 19, 2002
Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugationShufeng Zhou, Philip Kestell, James W Paxton
European Journal of Drug Metabolism and Pharmacokinetics|October 28, 2005
A comparison of glutathione S-transferase mutant frequencies in healthy Han and Uygur ChineseShi-Long Zhong, Shufeng Zhou, Min Huang
Pharmaceutical Research|March 24, 2006
Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection modelEli Chan, Shufeng Zhou, Sahasranaman Srikumar, et al.
Pharmaceutical Research|April 20, 2005
Significant intestinal excretion, one source of variability in pharmacokinetics of COL-3, a chemically modified tetracyclineJing Li, Shufeng Zhou, Hung Huynh, et al.
Drug Metabolism Reviews|June 4, 2005
An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in SingaporeBalram Chowbay, Shufeng Zhou, Edmund J D Lee
Therapeutics and Clinical Risk Management|March 25, 2008
Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4Shufeng Zhou, Eli Chan, Xiaotian Li, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 26, 2002
Strain differences in the liver microsomal metabolism of the experimental anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in miceShufeng Zhou, Philip Kestell, James W Paxton
Clinical and Experimental Pharmacology & Physiology|January 17, 2016
Multifaceted ability of naturally occurring polyphenols against metastatic cancerQingyu Zhou, Lunawati L Bennett, Shufeng Zhou
Drug Metabolism Reviews|April 10, 2004
Herbal modulation of P-glycoproteinShufeng Zhou, Lee Yong Lim, Balram Chowbay
The Journal of Pharmacy and Pharmacology|August 7, 2002
Non-specific binding of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in liver microsomes from various speciesShufeng Zhou, Philip Kestell, James W Paxton
Drug Metabolism Reviews|December 19, 2002
Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugationShufeng Zhou, Philip Kestell, James W Paxton
European Journal of Drug Metabolism and Pharmacokinetics|October 28, 2005
A comparison of glutathione S-transferase mutant frequencies in healthy Han and Uygur ChineseShi-Long Zhong, Shufeng Zhou, Min Huang
Pharmaceutical Research|March 24, 2006
Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection modelEli Chan, Shufeng Zhou, Sahasranaman Srikumar, et al.
Pharmaceutical Research|April 20, 2005
Significant intestinal excretion, one source of variability in pharmacokinetics of COL-3, a chemically modified tetracyclineJing Li, Shufeng Zhou, Hung Huynh, et al.
Drug Metabolism Reviews|June 4, 2005
An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in SingaporeBalram Chowbay, Shufeng Zhou, Edmund J D Lee
Therapeutics and Clinical Risk Management|March 25, 2008
Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4Shufeng Zhou, Eli Chan, Xiaotian Li, et al.
Pageof 15